|
Real-time
Boerse Muenchen
05:43:10 06/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 19.50 EUR | -0.51% |
|
-1.01% | -53.33% |
| Market Cap | 717M 640M 596M 542M 1.02B 69.04B 1.03B 7.2B 2.8B 35.24B 2.69B 2.63B 113B | P/E 2026 * |
13.2x | P/E 2027 * | 6.61x |
|---|---|---|---|---|---|
| Enterprise Value | 1.57B 1.4B 1.3B 1.19B 2.23B 151B 2.25B 15.75B 6.13B 77.09B 5.89B 5.76B 248B | EV / Sales 2026 * |
1.87x | EV / Sales 2027 * | 1.49x |
| Free-Float |
77.39% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| COLL | Delayed | |
CBOE
| COLL | Real-time | |
|
Deutsche Boerse AG
| 354 | Delayed | |
|
Börse Stuttgart
| 354 | Delayed | |
|
Boerse Muenchen
| 354 | Real-time | |
|
Tradegate
| 354 | Real-time |
Last Transcript: Collegium Pharmaceutical, Inc.
| 1 week | -1.01% | ||
| Current month | +1.03% | ||
| 1 month | -5.77% | ||
| 3 months | -39.51% | ||
| 6 months | -30.05% | ||
| Current year | -53.33% |
| 1 week | 19.2 |  | 20.2 |
| 1 month | 18.9 | | 20.8 |
| 3 years | 18.9 | | 42.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Vikram Karnani
CEO | Chief Executive Officer | 51 | 12/11/2024 |
Colleen Tupper
DFI | Director of Finance/CFO | 50 | 24/05/2021 |
Thomas Smith
CTO | Chief Tech/Sci/R&D Officer | 65 | 23/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gino Santini
CHM | Chairman | 69 | 15/05/2025 |
John Freund
BRD | Director/Board Member | 72 | 01/02/2014 |
Garen Bohlin
BRD | Director/Board Member | 78 | 01/01/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.51% | -1.01% | -33.33% | -9.26% | 717M | |
| +0.48% | -3.03% | +35.95% | +112.17% | 1,019B | |
| -1.01% | -6.81% | +34.69% | +61.28% | 617B | |
| +0.57% | -1.06% | +14.45% | +78.67% | 464B | |
| -3.11% | -5.97% | +57.44% | +34.95% | 356B | |
| +0.93% | -1.83% | +20.98% | +41.43% | 333B | |
| +0.12% | -4.05% | +10.09% | +33.53% | 267B | |
| -0.89% | -5.83% | -7.56% | +7.91% | 244B | |
| -0.23% | -3.72% | +36.87% | +51.86% | 218B | |
| -0.51% | -5.33% | +26.87% | +92.90% | 179B | |
| Average | -0.48% | -3.54% | +19.65% | +50.54% | 410.8B | |
| Weighted average by Cap. | -0.32% | -3.54% | +28.63% | +68.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 837M 747M 696M 633M 1.19B 80.62B 1.2B 8.41B 3.27B 41.15B 3.14B 3.07B 132B | 850M 758M 707M 643M 1.21B 81.87B 1.22B 8.54B 3.32B 41.79B 3.19B 3.12B 134B |
| Net income | 61.01M 54.43M 50.7M 46.14M 86.9M 5.88B 87.54M 613M 238M 3B 229M 224M 9.64B | 130M 116M 108M 98.42M 185M 12.53B 187M 1.31B 508M 6.4B 489M 478M 20.56B |
| Net Debt | 851M 760M 708M 644M 1.21B 81.99B 1.22B 8.55B 3.33B 41.85B 3.2B 3.13B 135B | 553M 493M 460M 418M 788M 53.27B 794M 5.55B 2.16B 27.19B 2.08B 2.03B 87.39B |
| Date | Price | Change |
|---|---|---|
| 06/10/26 | EUR 19.50 | -0.51% |
| 02/10/26 | EUR 19.60 | +0.51% |
| 01/10/26 | EUR 19.50 | +0.52% |
| 30/09/26 | EUR 19.40 | 0.00% |
| 29/09/26 | EUR 19.40 | -2.51% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COLL Stock
- 354 Stock
Select your edition
All financial news and data tailored to specific country editions
